STERIS plc·4

Jun 4, 4:33 PM ET

Majors Cary L 4

Research Summary

AI-generated summary

Updated

STERIS (STE) SVP Cary Majors Receives Award; 67 Shares Withheld

What Happened
Cary L. Majors, SVP and President, Healthcare at STERIS plc, received equity awards on June 2, 2026. The Form 4 reports acquisition of 4,746 ordinary restricted shares (no cash paid) and a derivative award covering 16,548 option-equivalent shares (granted at $0). On the same date, 67 shares were withheld to cover tax withholding obligations related to 2,140 restricted shares that vested; those 67 shares were valued at $209.76 each for a total of $14,054 and reported as a disposition (tax withholding).

Key Details

  • Transaction date: June 2, 2026 (Form 4 filed June 4, 2026 — timely).
  • Withholding: 67 shares withheld at $209.76 per share = $14,054 to satisfy taxes on vested restricted shares (code F).
  • Awards received: 4,746 ordinary restricted shares (code A) and 16,548 derivative/option-equivalent units (code A, derivative). Both reported as acquisitions at $0.
  • Restricted-share schedule (footnote): 10,047 of the ordinary shares are restricted; restrictions lapse 2,379 on 6/4/2027, 2,922 on 6/5/2028, and 4,746 on 6/4/2029.
  • Option exercisability (footnote): the 16,548-unit option vests/exercises in four tranches of 4,137 on 6/2/2027, 6/2/2028, 6/4/2029 and 6/3/2030.
  • Other: 67 ordinary-share equivalents are held on behalf of the reporting person in the STERIS 401(k) plan as of May 29, 2026.
  • No total post-transaction beneficial ownership was provided in the excerpted data.

Context
These entries reflect compensation-related awards (restricted stock and option-like units) and routine tax withholding, not an open-market purchase or a discretionary sale. The derivative award is subject to future exercisability/vesting per the schedule above; the 67-share disposition was a standard withholding to cover taxes on vested restricted shares.